Biora Therapeutics, Inc. (BIOR)
(Delayed Data from NSDQ)
$2.54 USD
-0.10 (-3.79%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $2.44 -0.10 (-3.94%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Earnings Date | *AMC11/14/24 |
---|---|
Current Quarter | -3.85 |
EPS Last Quarter | -3.50 |
Last EPS Surprise | 22.22% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -12.45 |
Next Year | -11.50 |
EPS (TTM) | -23.40 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.42M | 0.44M | 1.28M | 5.00M |
# of Estimates | 1 | 1 | 2 | 1 |
High Estimate | 0.42M | 0.44M | 1.70M | 5.00M |
Low Estimate | 0.42M | 0.44M | 0.86M | 5.00M |
Year ago Sales | 0.00M | 0.00M | 0.00M | 1.28M |
Year over Year Growth Est. | NA | NA | 31,900.00% | 290.63% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -3.85 | -3.70 | -12.45 | -11.50 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -3.50 | -3.10 | -16.50 | -9.30 |
High Estimate | -3.50 | -3.10 | -8.40 | -9.30 |
Low Estimate | -4.20 | -4.30 | -16.50 | -13.70 |
Year ago EPS | -7.50 | -6.30 | -78.80 | -12.45 |
Year over Year Growth Est. | 48.67% | 41.27% | 84.20% | 7.63% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -3.85 | -3.70 | -12.45 | -11.50 |
7 Days Ago | -3.85 | -3.70 | -12.45 | -11.50 |
30 Days Ago | -3.85 | -3.70 | -12.45 | -11.50 |
60 Days Ago | -3.85 | -3.70 | -12.45 | -11.50 |
90 Days Ago | -4.20 | -4.15 | -16.40 | -12.40 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -3.85 | -3.70 | -12.45 | -11.50 |
Zacks Consensus Estimate | -3.85 | -3.70 | -12.45 | -11.50 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -3.50 | -6.10 | -6.30 | -7.50 | NA |
Estimate | -4.50 | -4.50 | -6.00 | -9.30 | NA |
Difference | 1.00 | -1.60 | -0.30 | 1.80 | 0.23 |
Surprise | 22.22% | -35.56% | -5.00% | 19.35% | 0.25% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more